Cargando…

Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis

AIMS: Angioimmunoblastic T‐cell lymphoma (AITL) is genetically characterized by TET2 and DNMT3A mutations occurring in haematopoietic progenitor cells, and late events (e.g. the RHOA‐G17V mutation) associated with malignant transformation. As TET2/DNMT3A‐mutated progenitor cells can differentiate in...

Descripción completa

Detalles Bibliográficos
Autores principales: Attygalle, Ayoma D, Dobson, Rachel, Chak, Pui Kwan, Vroobel, Katherine M, Wren, Dorte, Mugalaasi, Hood, Morgan, Yvonne, Kaur, Manmit, Ahmad, Raida, Chen, Zi, Naresh, Kikkeri N, Du, Ming‐Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310594/
https://www.ncbi.nlm.nih.gov/pubmed/35064935
http://dx.doi.org/10.1111/his.14619
_version_ 1784753420114067456
author Attygalle, Ayoma D
Dobson, Rachel
Chak, Pui Kwan
Vroobel, Katherine M
Wren, Dorte
Mugalaasi, Hood
Morgan, Yvonne
Kaur, Manmit
Ahmad, Raida
Chen, Zi
Naresh, Kikkeri N
Du, Ming‐Qing
author_facet Attygalle, Ayoma D
Dobson, Rachel
Chak, Pui Kwan
Vroobel, Katherine M
Wren, Dorte
Mugalaasi, Hood
Morgan, Yvonne
Kaur, Manmit
Ahmad, Raida
Chen, Zi
Naresh, Kikkeri N
Du, Ming‐Qing
author_sort Attygalle, Ayoma D
collection PubMed
description AIMS: Angioimmunoblastic T‐cell lymphoma (AITL) is genetically characterized by TET2 and DNMT3A mutations occurring in haematopoietic progenitor cells, and late events (e.g. the RHOA‐G17V mutation) associated with malignant transformation. As TET2/DNMT3A‐mutated progenitor cells can differentiate into multilineage progenies and give rise to both AITL and myeloid neoplasms, they may also have the potential to lead to other metachronous/synchronous neoplasms. We report two cases showing parallel evolution of two distinct potentially neoplastic lymphoid proliferations from a common mutated haematopoietic progenitor cell population. METHODS AND RESULTS: Both cases presented with generalized lymphadenopathy. In case 1 (a 67‐year‐old female), an initial lymph node (LN) biopsy was dismissed as reactive, but a repeat biopsy showed a nodal marginal zone lymphoma (NMZL)‐like proliferation with an increase in the number of T‐follicular helper (TFH) cells. Immunohistochemistry, and clonality and mutational analyses by targeted sequencing of both whole tissue sections and microdissected NMZL‐like lesions, demonstrated a clonal B‐cell proliferation that harboured the BRAF‐G469R mutation and shared TET2 and DNMT3A mutations with an underlying RHOA‐G17V‐mutant TFH proliferation. Review of the original LN biopsy showed histological and immunophenotypic features of AITL. In case 2 (a 66‐year‐old male), cytotoxic T‐cell lymphoma with an increase in the number of Epstein–Barr virus‐positive large B cells was diagnosed on initial biopsy. On review together with the relapsed biopsy, we identified an additional occult neoplastic TFH proliferation/smouldering AITL. Both T‐cell proliferations shared TET2 and DNMT3A mutations while RHOA‐G17V was confined to the smouldering AITL. CONCLUSIONS: In addition to demonstrating diagnostic challenges, these cases expand the potential of clonal haematopoiesis in the development of different lineage neoplastic proliferations.
format Online
Article
Text
id pubmed-9310594
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93105942022-07-29 Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis Attygalle, Ayoma D Dobson, Rachel Chak, Pui Kwan Vroobel, Katherine M Wren, Dorte Mugalaasi, Hood Morgan, Yvonne Kaur, Manmit Ahmad, Raida Chen, Zi Naresh, Kikkeri N Du, Ming‐Qing Histopathology Original Articles AIMS: Angioimmunoblastic T‐cell lymphoma (AITL) is genetically characterized by TET2 and DNMT3A mutations occurring in haematopoietic progenitor cells, and late events (e.g. the RHOA‐G17V mutation) associated with malignant transformation. As TET2/DNMT3A‐mutated progenitor cells can differentiate into multilineage progenies and give rise to both AITL and myeloid neoplasms, they may also have the potential to lead to other metachronous/synchronous neoplasms. We report two cases showing parallel evolution of two distinct potentially neoplastic lymphoid proliferations from a common mutated haematopoietic progenitor cell population. METHODS AND RESULTS: Both cases presented with generalized lymphadenopathy. In case 1 (a 67‐year‐old female), an initial lymph node (LN) biopsy was dismissed as reactive, but a repeat biopsy showed a nodal marginal zone lymphoma (NMZL)‐like proliferation with an increase in the number of T‐follicular helper (TFH) cells. Immunohistochemistry, and clonality and mutational analyses by targeted sequencing of both whole tissue sections and microdissected NMZL‐like lesions, demonstrated a clonal B‐cell proliferation that harboured the BRAF‐G469R mutation and shared TET2 and DNMT3A mutations with an underlying RHOA‐G17V‐mutant TFH proliferation. Review of the original LN biopsy showed histological and immunophenotypic features of AITL. In case 2 (a 66‐year‐old male), cytotoxic T‐cell lymphoma with an increase in the number of Epstein–Barr virus‐positive large B cells was diagnosed on initial biopsy. On review together with the relapsed biopsy, we identified an additional occult neoplastic TFH proliferation/smouldering AITL. Both T‐cell proliferations shared TET2 and DNMT3A mutations while RHOA‐G17V was confined to the smouldering AITL. CONCLUSIONS: In addition to demonstrating diagnostic challenges, these cases expand the potential of clonal haematopoiesis in the development of different lineage neoplastic proliferations. John Wiley and Sons Inc. 2022-03-01 2022-04 /pmc/articles/PMC9310594/ /pubmed/35064935 http://dx.doi.org/10.1111/his.14619 Text en © 2022 The Authors. Histopathology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Attygalle, Ayoma D
Dobson, Rachel
Chak, Pui Kwan
Vroobel, Katherine M
Wren, Dorte
Mugalaasi, Hood
Morgan, Yvonne
Kaur, Manmit
Ahmad, Raida
Chen, Zi
Naresh, Kikkeri N
Du, Ming‐Qing
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis
title Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis
title_full Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis
title_fullStr Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis
title_full_unstemmed Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis
title_short Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis
title_sort parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310594/
https://www.ncbi.nlm.nih.gov/pubmed/35064935
http://dx.doi.org/10.1111/his.14619
work_keys_str_mv AT attygalleayomad parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT dobsonrachel parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT chakpuikwan parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT vroobelkatherinem parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT wrendorte parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT mugalaasihood parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT morganyvonne parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT kaurmanmit parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT ahmadraida parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT chenzi parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT nareshkikkerin parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis
AT dumingqing parallelevolutionoftwodistinctlymphoidproliferationsinclonalhaematopoiesis